title: PIK3CA rs7640662 (C/G) single nucleotide polymorphism lacks association with breast cancer cases in Persians.
abstract: Phosphatidylinositol-3-kinase (PI3K) is a group of enzymes involved in cellular growth, proliferation, differentiation, cell motility, intracellular trafficking, and survival that play very important roles in developing breast cancer. PIK3CA is a gene that encodes α catalytic subunit of this enzyme. A common polymorphism of PIK3CA, rs7640662 (C/G), was analyzed, and its association to breast cancer cases was determined. In this study, DNA was extracted from peripheral blood samples of 278 women suffering from breast cancer and 128 healthy women. Tetra-primer amplification refractory mutation system polymerase chain reaction (T-ARMS-PCR) method was performed to genotype rs7640662. P values and ODD ratios were measured using SPSS. P value less than 0.05 and ODD ratios more than 1 were considered as significant. All ODD ratios were less than 1, and P values were more than 0.05 showing that rs7640662 (C/G) and breast cancer are not significantly associated. However, the genotypes observed in the Persian population, as an ancient population living in the Middle East, was significantly different from the genotypes reported by HapMap for Asian populations. As a conclusion, rs7640662 was not associated with the risk of breast cancer in a Persian population; however, it was observed that heterozygote (GC) is the most common genotypes in both case and control samples.
authors.forename: Atefeh
authors.initials: A
authors.lastname: Mir
authors.forename: Mahdiyeh Harati
authors.initials: MH
authors.lastname: Sadegh
authors.forename: Zahra
authors.initials: Z
authors.lastname: Ahmadinia
authors.forename: Parham Jabbarzadeh
authors.initials: PJ
authors.lastname: Kaboli
keywords: ARMS-PCR; PIK3CA; breast cancer; rs7640662; single nucleotide polymorphism
references.citation: Cancer Res. 2004 Nov 1;64(21):7678-81
references.pmid: 15520168
references.citation: PLoS Genet. 2009 May;5(5):e1000477
references.pmid: 19492015
references.citation: CSH Protoc. 2006 Jun 01;2006(1):null
references.pmid: 22485786
references.citation: Oncogene. 2005 Feb 17;24(8):1477-80
references.pmid: 15608678
references.citation: Cell. 2006 May 19;125(4):733-47
references.pmid: 16647110
references.citation: Clin Cancer Res. 2005 Apr 15;11(8):2875-8
references.pmid: 15837735
references.citation: Methods Mol Biol. 2006;351:75-92
references.pmid: 16988427
references.citation: Hum Pathol. 2014 Apr;45(4):880-3
references.pmid: 24444464
references.citation: Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):14372-7
references.pmid: 23940356
references.citation: Nature. 2005 Oct 27;437(7063):1299-320
references.pmid: 16255080
references.citation: J Clin Oncol. 2006 Aug 10;24(23):3789-98
references.pmid: 16785472
references.citation: PLoS One. 2013 Sep 06;8(9):e72373
references.pmid: 24039754
references.citation: Mol Cell Biol. 1994 Sep;14(9):5929-38
references.pmid: 8065326
references.citation: Cancer Res. 2008 Aug 1;68(15):6084-91
references.pmid: 18676830
references.citation: Oncol Lett. 2014 Sep;8(3):1249-1254
references.pmid: 25120700
references.citation: Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10208-13
references.pmid: 20479250
references.citation: Genet Epidemiol. 2012 Sep;36(6):538-48
references.pmid: 22685040
references.citation: Cancer Cell. 2005 Jun;7(6):561-73
references.pmid: 15950905
references.citation: Cancer Res. 2005 Apr 1;65(7):2554-9
references.pmid: 15805248
references.citation: Int J Mol Epidemiol Genet. 2014 May 29;5(2):100-11
references.pmid: 24959314
references.citation: Hum Pathol. 2012 Dec;43(12):2207-12
references.pmid: 22705004
references.citation: Br J Cancer. 2009 Mar 24;100(6):993-1001
references.pmid: 19240718
references.citation: Cell. 1993 Mar 12;72(5):767-78
references.pmid: 7680959
references.citation: Cancer Biol Ther. 2004 Aug;3(8):772-5
references.pmid: 15254419
references.citation: Science. 2004 Apr 23;304(5670):554
references.pmid: 15016963
references.citation: J Biol Chem. 1990 Nov 15;265(32):19704-11
references.pmid: 2174051
references.citation: J Mammary Gland Biol Neoplasia. 2012 Dec;17(3-4):205-16
references.pmid: 22865098
references.citation: Front Oncol. 2014 Apr 14;4:64
references.pmid: 24782981
references.citation: J Clin Oncol. 2009 Feb 20;27(6):857-71
references.pmid: 19164214
references.citation: Appl Immunohistochem Mol Morphol. 2014 Jan;22(1):50-6
references.pmid: 24471188
references.citation: Neoplasma. 2014;61(4):461-7
references.pmid: 25027743
references.citation: Eur J Pharmacol. 2014 Oct 5;740:584-95
references.pmid: 24973693
references.citation: Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):802-7
references.pmid: 15647370
references.citation: Oncogene. 2008 Sep 18;27(41):5497-510
references.pmid: 18794884
references.citation: Eur J Cancer. 2012 Oct;48(15):2293-9
references.pmid: 22840369